Secondary and tertiary prevention of type 2 diabetes: a study protocol for a randomized, controlled trial in community pharmacies in bavaria, germany
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-CPS-081
- By: PRAX, Katja (Friedrich-Alexander University Erlangen-Nuremberg, Molecular & Clinical Pharmacy, Erlangen, Germany)
- Co-author(s): Katja Prax: Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
Helmut Schlager: Scientific Institute for Prevention in Health Care (WIPIG), Munich, Germany
Kristina Friedland: Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
Type 2 diabetes patients have a high risk for micro- and macrovascular complications. Hereby, a poor glycemic control leads to progression of disease, hospitalization and reduced life expectancy. In Germany there is lack of evidence regarding a community pharmacist intervention to improve glycemic control of diabetics.
The.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019